DiaSorin S.p.A.
DIA
Classement en actions
#3789
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Prix de l'action
$88.31
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$4.37B
Changement (1 jour)
-6.35%
Changement (1 an)
-2.42%
Pays
IT
Échange DiaSorin S.p.A. (DIA)
Catégorie
Healthcare
Ratio P/S pour DiaSorin S.p.A. (DIA)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de DiaSorin S.p.A., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour DiaSorin S.p.A. de 2026 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 5.37 | - |
US
|
|
| 6.29 | - |
US
|
|
| 21.02 | - |
US
|
|
| - | - |
CN
|
|
| 6.67 | - |
US
|
